Segmed, Inc., the leader in real-world imaging data for research and AI development, today announced the appointment of David ...

IQVIA Holdings reported strong Q1 earnings with $3.83B in revenue, driven by growth in the Technology & Analytics Solutions ...

Clinical research company IQVIA (NYSE: IQV) will be reporting earnings tomorrow before the bell. Here’s what to expect. IQVIA beat analysts’ revenue expectations by 0.6% last quarter ...

Clinical research company IQVIA (NYSE: IQV) reported Q1 CY2025 results topping the market’s revenue expectations , with sales up 2.5% year on year to $3.83 billion. The company’s full-year ...

The clinical testing company posted revenue of $3.83 billion in the period, which also beat Street forecasts. Nine analysts surveyed by Zacks expected $3.77 billion. IQVIA expects full-year earnings ...

CEO Bousbib reiterated that operational discipline and strategic focus position IQVIA well for navigating uncertainties. Compared to the prior quarter, a slight improvement in confidence was noted ...

Total net spending on medicines in 2029 is expected to increase by $116 billion compared to 2024, as volume growth drivers and adoption of innovation will be partly offset by drivers of lower ...

IQVIA Holdings Inc. reported its first-quarter 2025 earnings, showcasing a robust financial performance with adjusted earnings per share (EPS) of $2.70, surpassing the forecast of $2.64.

DURHAM, N.C. (AP) — DURHAM, N.C. (AP) — IQVIA Holdings Inc. (IQV) on Tuesday reported first-quarter profit of $249 million. On a per-share basis, the Durham, North Carolina-based company said ...

IQVIA Holdings (IQV) came out with quarterly earnings of $2.70 per share, beating the Zacks Consensus Estimate of $2.63 per share. This compares to earnings of $2.54 per share a year ago.